MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans.
|
22628558 |
2012 |
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY
|
0.700 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans.
|
22628558 |
2012 |
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Establishment of mitochondrial pyruvate carrier 1 (MPC1) gene knockout mice with preliminary gene function analyses.
|
27835892 |
2016 |
Organic Mental Disorders, Substance-Induced
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genome wide association for addiction: replicated results and comparisons of two analytic approaches.
|
20098672 |
2010 |
Substance Dependence
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genome wide association for addiction: replicated results and comparisons of two analytic approaches.
|
20098672 |
2010 |
Substance abuse problem
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genome wide association for addiction: replicated results and comparisons of two analytic approaches.
|
20098672 |
2010 |
Hypoglycemia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Global developmental delay
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Malignant neoplasm of prostate
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
However, the expression status of MPC1 and MPC2 in prostate cancer (PCA) is unclear.
|
27852261 |
2016 |
Malignant neoplasm of prostate
|
0.040 |
Biomarker
|
disease |
BEFREE |
However, the role of MPC1 in prostate cancer and the underlying mechanism causing the down-regulation of MPC1 in tumor cells remain to be defined.
|
26895100 |
2016 |
Malignant neoplasm of prostate
|
0.040 |
Biomarker
|
disease |
BEFREE |
Although MPC is composed of two subunits, it has been reported that the MPC1 subunit is specifically associated with poor prognosis in several cancers, including colorectal and prostate cancer.
|
29286150 |
2018 |
Malignant neoplasm of prostate
|
0.040 |
Biomarker
|
disease |
BEFREE |
Here we report our results in a prostate cancer cell line in which the mitochondrial pyruvate carrier 1 (MPC1) gene was knockout.
|
28624784 |
2017 |
Prostate carcinoma
|
0.040 |
Biomarker
|
disease |
BEFREE |
Here we report our results in a prostate cancer cell line in which the mitochondrial pyruvate carrier 1 (MPC1) gene was knockout.
|
28624784 |
2017 |
Prostate carcinoma
|
0.040 |
Biomarker
|
disease |
BEFREE |
Although MPC is composed of two subunits, it has been reported that the MPC1 subunit is specifically associated with poor prognosis in several cancers, including colorectal and prostate cancer.
|
29286150 |
2018 |
Prostate carcinoma
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
However, the expression status of MPC1 and MPC2 in prostate cancer (PCA) is unclear.
|
27852261 |
2016 |
Prostate carcinoma
|
0.040 |
Biomarker
|
disease |
BEFREE |
However, the role of MPC1 in prostate cancer and the underlying mechanism causing the down-regulation of MPC1 in tumor cells remain to be defined.
|
26895100 |
2016 |
Glioblastoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Furthermore, the inhibition of COUP-TFII was able to increase MPC1 expression and inhibit the growth of glioblastoma cells <i>in vitro</i> and <i>in vivo</i>.
|
29928345 |
2018 |
Glioblastoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
Among the four GBM subtypes, the proneural group had the highest MPC1 copy number segments and GBM patients diagnosed with proneural subtype showed the best outcome.
|
31236818 |
2019 |
Glioblastoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
Consistently, neither MPC1 nor MPC2 was predictive in a glioblastoma data set containing 5% IDH-mutant cases.
|
29547090 |
2018 |
Adult Glioblastoma
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
A total of 631 patients with glioblastoma (mean age 57.78 ± 14.36 years, 59% of males) were examined in this study, including 438 cases with MPC1 intact (MPC1 copy number segments > - 0.1, 69.4%) and 157 cases with MPC1 deletion (24.9%) tumors.
|
31236818 |
2019 |
Adult Glioblastoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Furthermore, the inhibition of COUP-TFII was able to increase MPC1 expression and inhibit the growth of glioblastoma cells <i>in vitro</i> and <i>in vivo</i>.
|
29928345 |
2018 |
Adult Glioblastoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
Consistently, neither MPC1 nor MPC2 was predictive in a glioblastoma data set containing 5% IDH-mutant cases.
|
29547090 |
2018 |